CDK5RAP3 and head and neck squamous cell carcinoma: CDK5RAP3 was initially considered as a putative tumor suppressor since it is found to be markedly reduced in 32% of primary head and neck squamous cell carcinoma (HNSCC), and inhibits cellular transformation and tumor growth in vitro and in vivo (5).